1. Home
  2. EYPT vs EBTC Comparison

EYPT vs EBTC Comparison

Compare EYPT & EBTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • EBTC
  • Stock Information
  • Founded
  • EYPT 1987
  • EBTC 1989
  • Country
  • EYPT United States
  • EBTC United States
  • Employees
  • EYPT N/A
  • EBTC 570
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • EBTC Major Banks
  • Sector
  • EYPT Industrials
  • EBTC Finance
  • Exchange
  • EYPT Nasdaq
  • EBTC Nasdaq
  • Market Cap
  • EYPT 489.4M
  • EBTC 525.8M
  • IPO Year
  • EYPT 2005
  • EBTC 2005
  • Fundamental
  • Price
  • EYPT $6.15
  • EBTC $42.45
  • Analyst Decision
  • EYPT Strong Buy
  • EBTC
  • Analyst Count
  • EYPT 8
  • EBTC 0
  • Target Price
  • EYPT $25.71
  • EBTC N/A
  • AVG Volume (30 Days)
  • EYPT 886.1K
  • EBTC 33.6K
  • Earning Date
  • EYPT 03-06-2025
  • EBTC 01-28-2025
  • Dividend Yield
  • EYPT N/A
  • EBTC 2.36%
  • EPS Growth
  • EYPT N/A
  • EBTC 0.32
  • EPS
  • EYPT N/A
  • EBTC 3.12
  • Revenue
  • EYPT $45,713,000.00
  • EBTC $168,758,000.00
  • Revenue This Year
  • EYPT N/A
  • EBTC N/A
  • Revenue Next Year
  • EYPT N/A
  • EBTC N/A
  • P/E Ratio
  • EYPT N/A
  • EBTC $13.61
  • Revenue Growth
  • EYPT 7.50
  • EBTC 4.53
  • 52 Week Low
  • EYPT $5.90
  • EBTC $22.60
  • 52 Week High
  • EYPT $29.31
  • EBTC $44.41
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 36.22
  • EBTC 50.84
  • Support Level
  • EYPT $5.90
  • EBTC $42.38
  • Resistance Level
  • EYPT $6.67
  • EBTC $43.95
  • Average True Range (ATR)
  • EYPT 0.71
  • EBTC 1.14
  • MACD
  • EYPT -0.04
  • EBTC -0.17
  • Stochastic Oscillator
  • EYPT 8.99
  • EBTC 54.63

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About EBTC Enterprise Bancorp Inc

Enterprise Bancorp Inc is a holding company engaged in the business of gathering deposits from the general public and investing in loans and investment securities. Through the Bank and its subsidiaries, the company offers a range of commercial, residential, and consumer loan products, deposit products, and cash management services, as well as wealth management and wealth services.

Share on Social Networks: